Tumor Could Provide Early Warning

New England Journal of Medicine Article — The Impact of Drug Shortages on Children with Cancer

/in /by

The December 27, 2012, New England Journal of Medicine includes an important research article on the impact of drug shortages on children with cancer.  The study, conducted by Drs. Monika Metzger, Amy Billett, and Michael Link, evaluated the impact of shortages of mechlorethamine for treatment of intermediate-risk Hodgkin’s lymphoma in children.  The authors found that treatment with cyclophosphamide, the substitute for mechlorethamine, was “significantly less effective” than treatment with mechlorethamine.  The full article is available online. Rob Stein reported on the NEJM study in NPR’s All Things Considered of Wednesday, December 26, 2012.

 

You might also like
SuperHero Posesquare NCCS Session at CancerCon 2015 Presents Two Types of Advocacy
20years 20 Years Later Series Wrap-Up: Julia Rowland Shares a History of the Imperatives and the Current Challenges in Survivorship
20years Guest Post by Dr. Melissa Hudson: How Has the Childhood Cancer Survivor Study Informed the Care of Children With Cancer?
NCCS Starburst 250px What Caught Our Eye: ACA Debate, Thyroid Cancer Late Effects, Long-Term Follow-Up Care, Cervical Cancer Mortality, and Anxiety in Partners of Breast Cancer Survivors
NCCS Starburst 250px Health Care Roundup: CMS Halts ACA Risk Payments, Slashes Navigator Funding; Long-Term Outcomes for Young Survivors; Drug Pricing; More
New York Times Thumbnail Supply of a cancer drug may run out within weeks
NCCS Starburst 250px What Caught Our Eye: GOP Lawmakers Face AHCA Backlash at Home, A Profile on New FDA Chief Scott Gottlieb, and Survivorship Care Planning
NCCS Starburst Thumbnail NCCS Responds to Recent Data on Childhood Cancer Survivorship Issues

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

NCCS Files Comments on Proposed Rule Setting Standards Related to Essential... Dome Thumbnail starburst Tumor Could Provide Early Warning Shared Decision Making to Improve Care and Reduce Costs